Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

508 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases].
Miehsler W, Dejaco C, Gröchenig HP, Fuchssteiner H, Högenauer C, Kazemi-Shirazi L, Maier H, Mayer A, Moschen A, Reinisch W, Petritsch W, Platzer R, Steiner P, Tilg H, Vogelsang H, Wenzl H, Novacek G. Miehsler W, et al. Among authors: tilg h. Z Gastroenterol. 2018 Mar;56(3):275-302. doi: 10.1055/s-0044-100044. Epub 2018 Mar 12. Z Gastroenterol. 2018. PMID: 29529682 German.
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working group.
Lochs H, Adler G, Beglinger C, Duchmann R, Emmrich J, Ewe K, Gangl A, Gasché C, Hahn E, Hoffmann P, Kaskas B, Malchow H, Pohl C, Raedler A, Renner E, Schölmerich J, Schreiber S, Stange E, Tilg H, Vogelsang H, Weigert N, Zeitz M. Lochs H, et al. Among authors: tilg h. Z Gastroenterol. 1999 Jun;37(6):509-12. Z Gastroenterol. 1999. PMID: 10427657 Clinical Trial.
Increased expression of CCL20 in human inflammatory bowel disease.
Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, Graziadei I, Dunzendorfer S, Wiedermann CJ, Mürzl E, Grasl E, Jasarevic Z, Romani N, Offner FA, Tilg H. Kaser A, et al. Among authors: tilg h. J Clin Immunol. 2004 Jan;24(1):74-85. doi: 10.1023/B:JOCI.0000018066.46279.6b. J Clin Immunol. 2004. PMID: 14997037
[Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
Tilg H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W; Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH. Tilg H, et al. Z Gastroenterol. 2004 Oct;42(10):1256-63. doi: 10.1055/s-2004-813567. Z Gastroenterol. 2004. PMID: 15508068 Review. German. No abstract available.
508 results